Meng-Lin Liu v. Siemens A.G.

978 F. Supp. 2d 325, 36 I.E.R. Cas. (BNA) 1698, 2013 WL 5692504, 2013 U.S. Dist. LEXIS 151005
CourtDistrict Court, S.D. New York
DecidedOctober 21, 2013
DocketNo. 13 Civ. 317(WHP)
StatusPublished
Cited by6 cases

This text of 978 F. Supp. 2d 325 (Meng-Lin Liu v. Siemens A.G.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Meng-Lin Liu v. Siemens A.G., 978 F. Supp. 2d 325, 36 I.E.R. Cas. (BNA) 1698, 2013 WL 5692504, 2013 U.S. Dist. LEXIS 151005 (S.D.N.Y. 2013).

Opinion

MEMORANDUM & ORDER

WILLIAM H. PAULEY III, District Judge:

Plaintiff Meng-Lin Liu brings this action under the Anti-Retaliation Provision of the Dodd-Frank Act. Defendant Siemens A.G. moves to dismiss under Federal Rule of Civil Procedure 12(b)(6). For the following reasons, Siemens’ motion is granted.

BACKGROUND

Meng-Lin Liu is a resident of Taiwan. In March 2008, Siemens China Ltd. hired Liu as the Group Compliance Officer for the company’s healthcare division. Later, he became Division Compliance Officer. Siemens China is a subsidiary of Siemens A.G., a German corporation. The healthcare division of Siemens China develops and manufactures medical equipment for sale to hospitals. Liu alleges the healthcare division engaged in a kickback scheme. According to his amended complaint, Siemens China routinely made inflated bids to sell medical imaging equipment to public hospitals in North Korea and China. When the bids were accepted, the equipment was sold through intermediaries who remitted a portion of the purchase price to the officials who accepted the bids.

In October 2009, Liu raised concerns about a deal in North Korea that he believed circumvented internal compliance procedures put in place after Siemens A.G.’s 2008 guilty plea to Foreign Corrupt Practices Act (FCPA) charges. In December 2009, he received a negative performance evaluation he believes was retaliation [327]*327for raising these concerns. But Liu continued to agitate, sending e-mails and giving presentations regarding what he viewed as systematic problems with Siemens’ compliance procedures. Specifically, he noted the deviations between Siemens’ bids to hospitals and the money Siemens actually received from third-party intermediaries in the transactions.

In April 2010, Liu attempted to implement a new procedure whereby Siemens China, the purchasing hospital, and the third-party intermediary would execute a single “tripartite” contract, which he believed would eliminate corruption risks. However, his superiors quashed any use of his new procedure and then retaliated by rejecting his application for travel expenses to attend Siemens’ internal global healthcare compliance conference in Germany. In June 2010, Liu refused to approve the use of particular intermediaries for bids to sell equipment to army hospitals in China. He was abruptly stripped of his authority to make such approvals.

In August 2010, Siemens China removed Liu’s responsibilities for overseeing any approval and compliance issues, limiting his role to “training, process improvements and other special tasks assigned by [the Regional Compliance Officer].”1 Liu used his newfound free time to compile documentation comparing price deviations between accepted bids and actual sales prices to intermediaries for all Chinese transactions in a three-month period. He found markups ranging from 25 to 133 percent. In October, Liu presented his findings to Stefan Mueller, Siemens China’s CFO for Healthcare.

A little over two weeks later, Liu spoke at a Siemens town hall meeting in Shanghai attended by Siemens China President and CEO Mei-Wei Cheng. Liu asserted that “compliance was low and that if [Siemens] were to follow compliance guidelines, Siemens would lose 30% of our healthcare business.”2 That same day, Liu received a letter instructing him not to report to work for the three months remaining on his employment contract. That contract, and Liu’s tenure with Siemens China, expired in March 2011. On May 17, 2011, Liu reported possible FCPA violations to the SEC.

DISCUSSION

I. Legal Standard

To survive a motion to dismiss, “a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’ ” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). To determine plausibility, courts follow a “two-pronged approach.” Iqbal, 556 U.S. at 679, 129 S.Ct. 1937. “First, although a court must accept as true all of the allegations contained in a complaint, that tenet is inapplicable to legal conclusions, and threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Harris v. Mills, 572 F.3d 66, 72 (2d Cir.2009) (internal punctuation omitted). Second, a court determines “whether the ‘well-pleaded factual allegations,’ assumed to be true, ‘plausibly give rise to an entitlement to relief.’ ” Hayden v. Paterson, 594 F.3d 150, 161 (2d Cir.2010) (quoting Iqbal, 556 U.S. at 679, 129 S.Ct. 1937). On a motion to dismiss, courts may consider “facts stated on the face of the complaint, in the documents appended to the complaint or incor[328]*328porated in the complaint by reference, and ... matters of which judicial notice may be taken.” Allen v. WestPoint-Pepperell, Inc., 945 F.2d 40, 44 (2d Cir.1991).

II. The Dodd Frank-Act Anti-Retaliation Provision

Liu brings this action under the Anti-Retaliation Provision of the Dodd-Frank Act, claiming he was illegally terminated for reporting possible FCPA violations. The Dodd-Frank Act’s Anti-Retaliation Provision provides, in relevant part, that

No employer may discharge, demote, suspend, threaten, harass, directly or indirectly, or in any other manner discriminate against, a whistleblower in the terms and conditions of employment because of any lawful act done by the whistleblower ... in making disclosures that are required or protected under the Sarbanes-Oxley Act of 2002 (15 U.S.C. 7201 et seq.), [the Securities Exchange Act of 1934 (15 U.S.C. § 78a et seq.) ], section 1513(e) of Title 18, and any other law, rule, or regulation subject to the jurisdiction of the [SEC].

15 U.S.C. § 78u-6(h)(l)(a). The DoddFrank Act defines a “whistleblower” as “any individual who provides ... information relating to a violation of the securities laws to the [SEC], in a manner established, by rule or regulation, by the [SEC].” 15 U.S.C. § 78u-6(a)(6).

a. Extraterritoriality

“ ‘Unless there is the affirmative intention of the Congress clearly expressed’ to give a statute extraterritorial effect, ‘we must presume it is primarily concerned with domestic concerns.’ ” Morrison v. Nat’l Austl. Bank Ltd., 561 U.S. 247, 130 S.Ct. 2869, 2877, 177 L.Ed.2d 535 (2010).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Prout v. Vladeck
316 F. Supp. 3d 784 (S.D. Illinois, 2018)
Liu v. Siemens AG
Second Circuit, 2014
Liu Meng-Lin v. Siemens AG
763 F.3d 175 (Second Circuit, 2014)
Bussing v. COR Clearing, LLC
20 F. Supp. 3d 719 (D. Nebraska, 2014)
Yang v. Navigators Group, Inc.
18 F. Supp. 3d 519 (S.D. New York, 2014)
Adhikari v. Daoud
994 F. Supp. 2d 831 (S.D. Texas, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
978 F. Supp. 2d 325, 36 I.E.R. Cas. (BNA) 1698, 2013 WL 5692504, 2013 U.S. Dist. LEXIS 151005, Counsel Stack Legal Research, https://law.counselstack.com/opinion/meng-lin-liu-v-siemens-ag-nysd-2013.